US Broker Ratings

Investor Outlook: Theravance Biopharma, Inc. (TBPH) Shows Promising Upside Potential of 60.70%

Theravance Biopharma, Inc. (NASDAQ: TBPH), a dynamic player in the biotechnology sector, is drawing attention with its substantial growth potential, evidenced by an impressive potential upside..

Personalis, Inc. (PSNL) Stock Analysis: Exploring a 51% Potential Upside in the Cancer Genomics Market

Personalis, Inc. (NASDAQ: PSNL) is carving a niche in the rapidly evolving healthcare sector, specifically within the diagnostics and research industry. With its focus on advanced..

Opthea Limited (OPT) Stock Analysis: Navigating a -60.90% Potential Downside in the Biotech Space

Opthea Limited (NASDAQ: OPT), a biopharmaceutical company headquartered in South Yarra, Australia, has garnered attention in the biotechnology sector for its innovative approach to treating eye..

Keros Therapeutics (KROS) Stock Analysis: A Biotech with a Staggering 254,413% Revenue Growth and Promising Upside

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector. With a focus on developing novel therapeutics for conditions linked..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Potential 199% Upside in Biotech Innovation

For investors with a keen eye on the biotechnology sector, MBX Biosciences, Inc. (NASDAQ: MBX) presents itself as a compelling opportunity. Based in Carmel, Indiana, MBX..

Kura Oncology, Inc. (KURA) Investor Outlook: Unveiling a 318% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) is turning heads in the biotechnology sector with its ambitious portfolio of cancer treatment candidates and a staggering 318% potential upside...

Zenas BioPharma, Inc. (ZBIO): Analyst Consensus Reveals 180% Upside Potential

Zenas BioPharma, Inc. (ZBIO) is capturing investor attention with a potential upside of 180.72%, according to recent analyst ratings. As a clinical-stage biopharmaceutical company based in..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Promising 252.99% Upside in the Biotech Sector

Oruka Therapeutics, Inc. (NASDAQ: ORKA) has emerged as a notable player in the biotechnology sector, capturing the attention of investors with its cutting-edge approach to developing..

Surmodics, Inc. (SRDX) Stock Analysis: Exploring a 47.46% Potential Upside in the Medical Devices Sector

Surmodics, Inc. (NASDAQ: SRDX) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical devices industry. Despite a challenging financial performance..

Septerna, Inc. (SEPN) Stock Analysis: Unpacking a Potential 149.65% Upside in Biotech

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology firm headquartered in South San Francisco, California, is capturing investor attention with a significant potential upside of 149.65%. Operating..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Potential 266% Upside in Biotech Investments

Xencor, Inc. (NASDAQ: XNCR) is capturing attention in the biotech investment landscape with a remarkable potential upside of 266.71%, according to analyst ratings. As a clinical-stage..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking the 398% Potential Upside in Biotech

Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing significant investor attention with a staggering potential upside of 398.48%, according to the latest analyst consensus. As a clinical-stage..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech with 341% Potential Upside and Growth Ambitions

Precigen, Inc. (NASDAQ: PGEN), a pioneering entity in the biotechnology sector, is making waves with a remarkable potential upside of 341.01%. This Germantown, Maryland-based company, with..

Valneva SE (VALN) Stock Analysis: A 111% Potential Upside Awaits Investors

Valneva SE (VALN), a prominent player in the healthcare sector, specifically within the biotechnology industry, is drawing attention from investors with a promising 111.16% potential upside...

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating Volatility in the Medical Devices Sector

Semler Scientific, Inc. (NASDAQ: SMLR) is an intriguing player in the healthcare sector, specifically within the medical devices industry. Headquartered in Santa Clara, California, the company..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 224% Upside Potential in the Booming Biotechnology Sector

Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage pharmaceutical innovator based in the United Kingdom, is making waves in the biotechnology sector with its pioneering approach to..

Abivax SA (ABVX) Stock Analysis: A 513.93% Potential Upside in the Biotechnology Sector

Abivax SA (ABVX), a biotechnology company headquartered in Paris, France, is capturing investor attention with its impressive growth potential. Specializing in developing therapeutics that stabilize immune..

Syndax Pharmaceuticals, Inc. (SNDX)

⚠️ No article content returned.

..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Unveiling a Potential 213% Upside

Investors seeking opportunities in the biotechnology sector may find Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) an intriguing candidate, thanks to its promising drug pipeline and substantial potential..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Exploring a Potential 104.79% Upside Despite Current Challenges

In the dynamic world of biotechnology, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands out as a unique player, offering a diverse range of products that significantly..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds